213 related articles for article (PubMed ID: 12130713)
1. Ischemia promotes renin activation and angiotensin formation in sympathetic nerve terminals isolated from the human heart: contribution to carrier-mediated norepinephrine release.
Seyedi N; Koyama M; Mackins CJ; Levi R
J Pharmacol Exp Ther; 2002 Aug; 302(2):539-44. PubMed ID: 12130713
[TBL] [Abstract][Full Text] [Related]
2. Activation of a renin-angiotensin system in ischemic cardiac sympathetic nerve endings and its association with norepinephrine release.
Levi R; Silver RB; Mackins CJ; Seyedi N; Koyama M
Int Immunopharmacol; 2002 Dec; 2(13-14):1965-73. PubMed ID: 12489810
[TBL] [Abstract][Full Text] [Related]
3. Angiotensin-converting enzyme-independent angiotensin formation in a human model of myocardial ischemia: modulation of norepinephrine release by angiotensin type 1 and angiotensin type 2 receptors.
Maruyama R; Hatta E; Yasuda K; Smith NC; Levi R
J Pharmacol Exp Ther; 2000 Jul; 294(1):248-54. PubMed ID: 10871319
[TBL] [Abstract][Full Text] [Related]
4. Effects of chronic treatment with losartan and enalaprilat on [3H]-norepinephrine release from isolated atria of Wistar-Kyoto and spontaneously hypertensive rats.
Foucart S; Patrick SK; Oster L; de Champlain J
Am J Hypertens; 1996 Jan; 9(1):61-9. PubMed ID: 8834708
[TBL] [Abstract][Full Text] [Related]
5. Angiotensin II increases norepinephrine release from atria by acting on angiotensin subtype 1 receptors.
Brasch H; Sieroslawski L; Dominiak P
Hypertension; 1993 Nov; 22(5):699-704. PubMed ID: 8225530
[TBL] [Abstract][Full Text] [Related]
6. Coupling of angiotensin II AT1 receptors to neuronal NHE activity and carrier-mediated norepinephrine release in myocardial ischemia.
Reid AC; Mackins CJ; Seyedi N; Levi R; Silver RB
Am J Physiol Heart Circ Physiol; 2004 Apr; 286(4):H1448-54. PubMed ID: 14684374
[TBL] [Abstract][Full Text] [Related]
7. Interactions between the renin-angiotensin system (RAS) and the sympathetic system.
Dendorfer A; Raasch W; Tempel K; Dominiak P
Basic Res Cardiol; 1998; 93 Suppl 2():24-9. PubMed ID: 9833158
[TBL] [Abstract][Full Text] [Related]
8. Cardiac mast cell-derived renin promotes local angiotensin formation, norepinephrine release, and arrhythmias in ischemia/reperfusion.
Mackins CJ; Kano S; Seyedi N; Schäfer U; Reid AC; Machida T; Silver RB; Levi R
J Clin Invest; 2006 Apr; 116(4):1063-70. PubMed ID: 16585966
[TBL] [Abstract][Full Text] [Related]
9. Ectonucleotidase in sympathetic nerve endings modulates ATP and norepinephrine exocytosis in myocardial ischemia.
Sesti C; Koyama M; Broekman MJ; Marcus AJ; Levi R
J Pharmacol Exp Ther; 2003 Jul; 306(1):238-44. PubMed ID: 12676879
[TBL] [Abstract][Full Text] [Related]
10. Effects of Losartan, a nonpeptide angiotensin II receptor antagonist, on norepinephrine overflow and antidiuresis induced by stimulation of renal nerves in anesthetized dogs.
Suzuki Y; Matsumura Y; Egi Y; Morimoto S
J Pharmacol Exp Ther; 1992 Dec; 263(3):956-63. PubMed ID: 1469652
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of sympathetic outflow by the angiotensin II receptor antagonist, eprosartan, but not by losartan, valsartan or irbesartan: relationship to differences in prejunctional angiotensin II receptor blockade.
Ohlstein EH; Brooks DP; Feuerstein GZ; Ruffolo RR
Pharmacology; 1997 Nov; 55(5):244-51. PubMed ID: 9399334
[TBL] [Abstract][Full Text] [Related]
12. Beta 2-adrenergic receptor and angiotensin II receptor modulation of sympathetic neurotransmission in human atria.
Rump LC; Schwertfeger E; Schaible U; Fraedrich G; Schollmeyer P
Circ Res; 1994 Mar; 74(3):434-40. PubMed ID: 8118951
[TBL] [Abstract][Full Text] [Related]
13. Bradykinin B2-receptor activation augments norepinephrine exocytosis from cardiac sympathetic nerve endings. Mediation by autocrine/paracrine mechanisms.
Seyedi N; Win T; Lander HM; Levi R
Circ Res; 1997 Nov; 81(5):774-84. PubMed ID: 9351450
[TBL] [Abstract][Full Text] [Related]
14. EctoNucleotidase in cardiac sympathetic nerve endings modulates ATP-mediated feedback of norepinephrine release.
Sesti C; Broekman MJ; Drosopoulos JH; Islam N; Marcus AJ; Levi R
J Pharmacol Exp Ther; 2002 Feb; 300(2):605-11. PubMed ID: 11805223
[TBL] [Abstract][Full Text] [Related]
15. Effects of angiotensin II and angiotensin-converting enzyme inhibitors on human myocardium.
Lenz O; Schmid B; Kilter H; La Rosée K; Flesch M; Kuhn-Regnier F; Südkamp M; Böhm M
Eur J Pharmacol; 1995 Dec; 294(1):17-27. PubMed ID: 8788412
[TBL] [Abstract][Full Text] [Related]
16. Involvement of the AT(2)-receptor in angiotensin II-induced facilitation of sympathetic neurotransmission.
Balt JC; Mathy MJ; Nap A; Pfaffendorf M; van Zwieten PA
J Renin Angiotensin Aldosterone Syst; 2002 Sep; 3(3):181-7. PubMed ID: 12563569
[TBL] [Abstract][Full Text] [Related]
17. Histamine 3 receptor activation reduces the expression of neuronal angiotensin II type 1 receptors in the heart.
Hashikawa-Hobara N; Chan NY; Levi R
J Pharmacol Exp Ther; 2012 Jan; 340(1):185-91. PubMed ID: 22011436
[TBL] [Abstract][Full Text] [Related]
18. Altered effects of angiotensin ii type 1 and type 2 receptor blockers on cardiac norepinephrine release and inotropic responses during cardiac sympathetic nerve stimulation in aorto-caval shunt rats.
Suzuki H; Maehara K; Yaoita H; Maruyama Y
Circ J; 2004 Jul; 68(7):683-90. PubMed ID: 15226636
[TBL] [Abstract][Full Text] [Related]
19. Exogenous angiotensin II does not facilitate norepinephrine release in the heart.
Lameris TW; de Zeeuw S; Duncker DJ; Alberts G; Boomsma F; Verdouw PD; van den Meiracker AH
Hypertension; 2002 Oct; 40(4):491-7. PubMed ID: 12364352
[TBL] [Abstract][Full Text] [Related]
20. Differential inhibition of the prejunctional actions of angiotensin II in rat atria by valsartan, irbesartan, eprosartan, and losartan.
Shetty SS; DelGrande D
J Pharmacol Exp Ther; 2000 Jul; 294(1):179-86. PubMed ID: 10871310
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
